Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 1975-1982

  Belvisi, M G ^a   Wicks, S L ^a   Battram, C H ^a   Bottoms, S E W ^a   Redford, J E ^a   Woodman, P ^a   Brown, T J ^a   Webber, S E ^a   Foster, M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE; GLUCOCORTICOID; PREDNISOLONE; RU 24858; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DISSOCIATION; DRUG POTENCY; GENE EXPRESSION; GENE REPRESSION; LUNG EDEMA; MALE; NONHUMAN; OSTEOPENIA; PRIORITY JOURNAL; RAT; TRANSACTIVATION;

EID: 0035253604     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.1975     Document Type: Article

References (22)

1. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
2. Efficacy and safety of inhaled glucocorticoids: An update
3. Control of transcriptional activation by steroid hormone receptors
4. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
5. Steroid hormone receptors: Many actors searching for a plot
6. Therapeutic potential of selective modulators or receptor action
7. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo
8. Does the synthetic glucocorticoid, RU 24858, which dissociates transactivation and transrepression in vitro possess anti-inflammatory properties without steroid adverse side effects in vivo?
9. Anti-inflammatory properties of Ebselen in a model of Sephadex-induced lung inflammation
10. Effects of a novel airway selective 17-thiosteroid RPR 106541 on biomarkers of systemic glucocorticoid exposure following 7 day oral administration in the rat
11. Transcriptional cross talk, the second mode of steroid hormone receptor action
12. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1
13. Glucocorticoid receptor transcription activity determined by spacing of receptor and nonreceptor DNA sites
14. The transcriptional coactivators p300 and CBP are histone acetyltransferases
15. DNA binding of the glucocorticoid receptor is not essential for survival
16. New insights into glucocorticoid and mineralocorticoid signaling: Lessons from gene targeting
17. Mutagenesis of the glucocorticoid receptor in mice
18. Dissociated glucocorticoids with anti-inflammatory potential repress IL-6 gene expression by nuclear factor κB-dependent mechanism
19. Glucocorticoids in T cell development and function
20. New developments in the pathogenesis and treatment of steroid-induced osteoporosis
21. A NF-κB/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes
22. Isolation of a cDNA clone, encoding a human β-galactoside binding protein, overexpressed during glucocorticoid-induced cell death